Sleep Management Institute is a Center of Excellence for the Inspire® Upper Air Way Stimulation device, a new FDA-approved device designed to treat Obstructive Sleep Apnea (OSA), a condition that repeatedly interrupts sleep due to a collapse of the airway and affects about 18 million Americans according to the National Sleep Foundation.
Patients with sleep apnea never get proper rest and often complain of all-day exhaustion. Research shows patients with poorly managed OSA are at increased risk for heart attack, stroke, weight gain, high blood pressure, heart failure and falling asleep while driving. Sleep apnea can also cause depression, spousal issues, irritability and daytime fatigue.
The first-line of defense for sleep apnea is continuous positive airway pressure (CPAP) machines. Patients wear a mask that keeps the airway open by blowing air into the nose and mouth during sleep. However, CPAP is not effective if patients do not wear their mask or cannot tolerate the therapy. Inspire therapy may be an appropriate alternative to CPAP for certain patients.